undamentalytics Newsletter
Sign in

Caretrust Reit, Inc. (CTRE) stock

Add to watchlist

Add holding +

NYSE: CTRE NYSE Health Care REITs Next results ~November 5, 2026

B Fundamentals grade

Caretrust Reit, Inc. is a US-listed company in the health care REITs industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$29

Valuation models combined (2)

Base case. Range ~$14–$37. Weighted average of 2 models (funds-from-operations model, dividend discount (growing dividend)), the funds-from-operations model counting double.

Price vs value

No Buy/Hold/Sell rating is issued: only 2 valuation models apply; a rating needs 3.

Caretrust Reit, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds277 adding, 199 cuttingOf 63 active managers that changed their stake, 37 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Caretrust Reit files

Where Caretrust Reit stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $571m, up 53.0% on a year earlier, slower than the 58.4% growth a quarter earlier. That growth ranks 2 of 15 among the health care reits companies we cover. The diluted share count is up 23.8% on a year earlier, which dilutes existing holders.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 5, 2026 (estimated)

Caretrust Reit, Inc.'s trailing-twelve-month revenue grew 53.0% year on year, with a free-cash-flow margin of 58.3%. Where it stands out: long-term debt as % of assets of 20.3% ranks 1 of 14 health care reits companies we cover. Where it lags: change in growth rate of -5.4pp ranks 16 of 17 health care reits companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 35.5% while net income grew 61.6%: a 26pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 53.0% over the last 12 months, against a median of 15.0% for health care reits companies we cover.
  • Strong cash generation. 58.3% of revenue turned into free cash flow.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 7.7% over 90 days.

Things to watch

  • Results due soon. Results are expected around 4 November; the share price can move sharply on the day.
  • Growth slowing. The growth rate is 5.4 points lower than a quarter earlier.
  • Share dilution. Diluted shares rose 23.8% in a year.
  • High debt. Long-term debt exceeds cash by $1.2bn, more than 1.5 times annual revenue.
  • High sales multiple. The shares trade at 14 times revenue while operating margins remain thin.
  • Missing expectations. Earnings per share fell short of the consensus estimate in 3 of the last four quarters.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
$0.39 against an average estimate of $0.39: beat by 0.3%
Revenue
$161m, up 43.5% on a year earlier
Share reaction
+0.2% in the first session after the results on August 6, 2026, against +0.5% for the S&P 500
Guidance given
net income attributable to CareTrust per share $1.53 to $1.56 (2026); normalized FFO per share $2.03 to $2.06 (2026)
Next report
November 5, 2026; average EPS estimate $0.43

Caretrust Reit's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-0.7%
  • 1 week-2.3%
  • 1 month-0.4%
  • This year+3.1%
  • 1 year+8.6%
  • 5 years+122.2%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$571M
Net margin
62.2%
EPS (TTM, diluted)
$1.59

Growth

Revenue growth
+53.0%
Change in growth rate
−5.4 pts
Share count change
+23.8%

Earnings

Last results
August 6, 2026
Next results (est.)
November 4, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Agreement
  2. Deal
  3. Results
  4. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Caretrust Reit, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 2 valuation models apply; a rating needs 3.

Valuation models

We value Caretrust Reit, Inc. as an equity reit, with every model that fits that kind of business. Cost of equity 7.8%: the 10-year Treasury yield (4.9%) plus a beta of 0.64 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Funds-from-operations model Funds from operations growing 2.5% a year, discounted at 8%. ~$37 ~$31–$45 Primary model, counts double
Price-to-FFO vs peers Funds from operations per share times peers' typical (harmonic-mean) price-to-FFO. ~$0.7 ~$17–$34 Left out: out of range vs price (0.02x)
Dividend discount (growing dividend) Today's dividend growing 2.5% a year, discounted at the cost of equity. ~$14 ~$12–$18 Included
Combined value Weighted average of the models that apply: the primary model (funds-from-operations model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$29 ~$14–$37 2 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Caretrust Reit, Inc. with equity REITs in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

55 /100

Moderate moat

How hard Caretrust Reit's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 3 / 20

    Net income has been a median 3.4% of total assets over 10 years.

  • Durability 12 / 20

    Net margin has been a median 29.8%; its worst year was 3.9%.

  • Cash conversion 20 / 20

    Free cash flow was positive in 10 of 10 years, at a median 56.5% of revenue.

  • Discipline 10 / 20

    The diluted share count rose 134.1% over five years; stock-based pay has been a median 2.4% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 5, 2026, after the close. Analysts expect revenue of $159m and EPS of $0.43 (range $0.40 to $0.52) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $1.72 +27% $627m +32%
Next $1.88 +9% $824m +31%

Next year's EPS estimate has moved +7.7% in 90 days, across 4 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −4.9% on 90 days ago. In the last 30 days, 0 analysts raised Caretrust Reit, Inc.'s forecast and 1 cut it.

Consensus EPS forecast Caretrust Reit, Inc., last 90 days
$1.70 $1.75 $1.80 $1.85 $1.90 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $1.80 Current fiscal year, 60 days ago: $1.81 Current fiscal year, 30 days ago: $1.73 Current fiscal year, 7 days ago: $1.77 Current fiscal year, Now: $1.72 $1.72 Next fiscal year, 90 days ago: $1.74 Next fiscal year, 60 days ago: $1.77 Next fiscal year, 30 days ago: $1.77 Next fiscal year, 7 days ago: $1.86 Next fiscal year, Now: $1.88 $1.88

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $1.80$1.74
60 days ago $1.81$1.77
30 days ago $1.73$1.77
7 days ago $1.77$1.86
Now $1.72$1.88

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.39 $0.39 +0.3%
Mar 2026 $0.36 $0.36 −1.3%
Dec 2025 $0.38 $0.36 −6.8%
Sept 2025 $0.38 $0.33 −13.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 6, 2026
  • Cash rental revenue 2026 about $454m Raised
    “Cash rental revenue of $454 million at the midpoint” source
  • net income attributable to CareTrust per share 2026 $1.53 to $1.56 GAAP Raised
    “The Company provided updated guidance for 2026, projecting net income attributable to CareTrust of approximately $1.53 to $1.56 per share, Normalized FFO of approximately $2.03 to $2.06 per share, and Normalized FAD of approximately $2.01 to $2.04 per share.” source
  • Normalized FFO per share 2026 $2.03 to $2.06 Non-GAAP Raised
    “The Company provided updated guidance for 2026, projecting net income attributable to CareTrust of approximately $1.53 to $1.56 per share, Normalized FFO of approximately $2.03 to $2.06 per share, and Normalized FAD of approximately $2.01 to $2.04 per share.” source
  • Normalized FAD per share 2026 $2.01 to $2.04 Non-GAAP Raised
    “The Company provided updated guidance for 2026, projecting net income attributable to CareTrust of approximately $1.53 to $1.56 per share, Normalized FFO of approximately $2.03 to $2.06 per share, and Normalized FAD of approximately $2.01 to $2.04 per share.” source
  • Net income attributable to CareTrust REIT, Inc. 2026 $356m to $364m GAAP Raised
    “Net income attributable to CareTrust REIT, Inc. $ 356 $ 364 $ 1.53 $ 1.56” source
  • Normalized FFO 2026 $472m to $480m Non-GAAP Raised
    “Normalized FFO $ 472 $ 480 $ 2.03 $ 2.06” source
Show 5 more items
  • Interest income from financing receivables 2026 about $43m Raised
    “Interest income from financing receivables of $43 million at the midpoint” source
  • Interest income from loans and other investments 2026 about $100m Raised
    “Interest income from loans and other investments of $100 million at the midpoint” source
  • General and administrative expense 2026 about $63m Raised
    “General and administrative expense of $63 million at the midpoint” source
  • Interest expense 2026 about $61m Raised
    “Interest expense of $61 million at the midpoint” source
  • Income tax expense 2026 about $10m Raised
    “Income tax expense of $10 million at the midpoint” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

14 analysts, Oct 2026
Buy1286%
Hold214%
Sell00%

Monthly trend

  1. Oct 2026210214
  2. Sep 2026210113
  3. Aug 2026210113
  4. Jul 202631013

Counts of recommendations published by analysts covering Caretrust Reit, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
5.1%
of tradable shares
Days to cover
3.81
at average volume
Short interest, 1 month
−38%
to October 15, 2026
Held by institutions
—
of shares
Held by insiders
0.8%
of shares
Employees
43
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +8.6%

$33.29 on October 31, 2025 to $36.14

ThenNowEffect
Revenue (last 12 months) $373m $571m +53.0%
Net margin 58.9% 62.2% +5.6%
P/E multiple 27.3x 22.7x −16.8%
Share count 181m 224m −19.2%

Biggest factor: revenue.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CTRE+8%−14%+27%+26%+39%+3%
Industry peers (median)+4%−21%+2%+12%+17%+13%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CTRE58%58%58%67%58%46%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CTRE−18%−29%−15%−18%−10%−18%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 67% from May 21, 2019 to March 18, 2020. Getting back needed a 207% gain, reached on February 1, 2021, 320 days after the low.

Price behaviour

52-week range
$33.92 – $42.95
From 52-week high
−15.8%
vs 50-day average
−3.0%
vs 200-day average
−5.7%
Volatility (1 year)
25%
Beta vs S&P 500
-0.03

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
9 up, 3 down
typical move ±2.7%
After a week
7 up, 5 down
typical move ±3.4%
After a month
8 up, 4 down
typical move ±5.9%
Results releasedNext dayS&P 500 next day5 days21 days
August 6, 2026 +0.2% +0.5% −5.6% −5.2%
May 7, 2026 +5.4% +0.5% +6.2% −6.5%
February 12, 2026 +1.6% −1.5% +1.7% +1.9%
November 5, 2025 +0.5% −0.7% +2.3% +6.5%
August 6, 2025 −0.7% +0.7% +0.9% +3.5%
May 1, 2025 −2.5% +2.2% −1.1% −1.1%
February 12, 2025 +3.0% +0.7% −0.5% +10.4%
October 29, 2024 +4.8% −0.1% −1.5% −4.5%
August 2, 2024 −1.1% −4.7% +2.4% +8.6%
May 2, 2024 +0.2% +2.2% −1.5% +3.5%
February 8, 2024 +9.0% +0.6% +10.0% +13.5%
November 9, 2023 +3.5% +0.8% +7.1% +5.1%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Caretrust Reit, Inc. in five measures

Fundamentals grade B
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Caretrust Reit, Inc.
$200M $300M $400M $500M $600M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $209.8M Revenue (TTM), FY23 Q4: $217.8M Revenue (TTM), FY24 Q1: $230.2M Revenue (TTM), FY24 Q2: $247.6M Revenue (TTM), FY24 Q3: $269.1M Revenue (TTM), FY24 Q4: $296.3M Revenue (TTM), FY25 Q1: $329.8M Revenue (TTM), FY25 Q2: $373.4M Revenue (TTM), FY25 Q3: $428.5M Revenue (TTM), FY25 Q4: $476.4M Revenue (TTM), FY26 Q1: $522.6M Revenue (TTM), FY26 Q2: $571.4M $571.4M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $209.8M
FY23 Q4 $217.8M
FY24 Q1 $230.2M
FY24 Q2 $247.6M
FY24 Q3 $269.1M
FY24 Q4 $296.3M
FY25 Q1 $329.8M
FY25 Q2 $373.4M
FY25 Q3 $428.5M
FY25 Q4 $476.4M
FY26 Q1 $522.6M
FY26 Q2 $571.4M
Revenue growth, TTM YoY Caretrust Reit, Inc.
0% 20% 40% 60% 80% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 8.1% Revenue growth, TTM YoY, FY23 Q4: 11.0% Revenue growth, TTM YoY, FY24 Q1: 15.0% Revenue growth, TTM YoY, FY24 Q2: 21.2% Revenue growth, TTM YoY, FY24 Q3: 28.2% Revenue growth, TTM YoY, FY24 Q4: 36.1% Revenue growth, TTM YoY, FY25 Q1: 43.3% Revenue growth, TTM YoY, FY25 Q2: 50.8% Revenue growth, TTM YoY, FY25 Q3: 59.2% Revenue growth, TTM YoY, FY25 Q4: 60.8% Revenue growth, TTM YoY, FY26 Q1: 58.4% Revenue growth, TTM YoY, FY26 Q2: 53.0% 53.0%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 8.1%
FY23 Q4 11.0%
FY24 Q1 15.0%
FY24 Q2 21.2%
FY24 Q3 28.2%
FY24 Q4 36.1%
FY25 Q1 43.3%
FY25 Q2 50.8%
FY25 Q3 59.2%
FY25 Q4 60.8%
FY26 Q1 58.4%
FY26 Q2 53.0%
FCF margin (TTM) Caretrust Reit, Inc.
40% 50% 60% 70% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 45.7% FCF margin (TTM), FY23 Q4: 47.6% FCF margin (TTM), FY24 Q1: 50.4% FCF margin (TTM), FY24 Q2: 54.9% FCF margin (TTM), FY24 Q3: 58.4% FCF margin (TTM), FY24 Q4: 63.3% FCF margin (TTM), FY25 Q1: 62.3% FCF margin (TTM), FY25 Q2: 65.9% FCF margin (TTM), FY25 Q3: 62.3% FCF margin (TTM), FY25 Q4: 63.2% FCF margin (TTM), FY26 Q1: 59.0% FCF margin (TTM), FY26 Q2: 58.3% 58.3%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 45.7%
FY23 Q4 47.6%
FY24 Q1 50.4%
FY24 Q2 54.9%
FY24 Q3 58.4%
FY24 Q4 63.3%
FY25 Q1 62.3%
FY25 Q2 65.9%
FY25 Q3 62.3%
FY25 Q4 63.2%
FY26 Q1 59.0%
FY26 Q2 58.3%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 42 49 59 75 105 133 157 163 178 192 196 218 296 476 571
Gross profit — — — — 102 130 154 161 176 192 — — — — —
Net income 0 −0 −8 10 29 26 58 46 81 72 −8 54 125 321 355
Diluted EPS $0.00 −$0.02 −$0.36 $0.26 $0.52 $0.35 $0.72 $0.49 $0.85 $0.74 −$0.08 $0.50 $0.80 $1.57 $1.59
Growth (year on year)
Revenue — +16.0% +20.7% +27.3% +39.7% +27.0% +18.0% +4.1% +9.1% +7.9% +2.0% +11.0% +36.1% +60.8% +53.0%
Net income — — — — +192.5% −11.9% +123.9% −20.0% +74.4% −11.0% −110.4% — +132.8% +156.3% +61.6%
Diluted EPS — — — — +100.0% −32.7% +105.7% −31.9% +73.5% −12.9% −110.8% — +60.0% +96.3% +30.6%
Margins
Gross margin — — — — 97.6% 97.9% 98.1% 98.2% 99.0% 100.0% — — — — —
Net margin 0.3% −0.8% −13.8% 13.4% 28.0% 19.5% 36.9% 28.4% 45.3% 37.4% −3.8% 24.7% 42.2% 67.3% 62.2%
Free-cash-flow margin 10.4% 13.7% 4.5% 53.3% 61.4% 66.5% 62.2% 75.5% 81.7% 81.6% 73.6% 71.1% 82.4% 82.7% 78.2%
Cash flow
Cash from operations 24 27 22 40 64 89 99 126 146 157 144 155 244 394 447
Capital spending 20 20 19 0 0 0 2 3 0 0 0 0 0 0 0
Free cash flow 4 7 3 40 64 88 98 123 146 157 144 155 244 394 447
Stock-based pay — 0 0 2 2 2 4 4 4 11 6 5 6 12 11
Free cash flow after stock pay — 7 2 38 63 86 94 119 142 146 139 150 238 382 436
Balance sheet
Cash 1 1 25 11 8 7 37 20 19 20 13 294 214 198 48
Total debt 0 259 358 400 455 565 495 560 550 680 725 600 400 900 1,210
Net debt (negative = net cash) −1 258 333 389 448 558 458 540 531 660 712 306 186 702 1,162
Diluted shares 22m 22m 23m 37m 56m 73m 79m 93m 95m 96m 97m 106m 155m 204m 224m
Returned to shareholders
Dividends — 0 33 22 37 53 63 81 93 101 106 115 172 259 305
Total returned — 0 33 22 37 53 63 81 93 101 106 115 172 259 305

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

Dividends (TTM)
$305M
Returned to shareholders
92%
of free cash flow
Diluted share count
+23.8%
year over year
Total shareholder yield
3.6%
dividends 3.6% + buybacks 0.0% of market value
Dividend payout ratio
86%
of net income paid out

Competitors: side by side with peers

Closest by revenue in health care reits
Last 12 months unless stated CTRE NHI DEA SBRA LTC NHP Median
Revenue, last 12 months $571m $432m $365m $919m $348m $344m $919m
Revenue growth, last 12 months 53.0% 23.9% 11.4% 23.4% 59.8% −1.2% 15.0%
Revenue growth, 3-year average 40.9% 12.0% 8.2% 12.3% 22.5% 0.2% 12.0%
Revenue growth, latest quarter 43.5% 33.8% 8.7% 31.3% 64.1% 2.6% 11.1%
Gross margin 100.0% — 77.2% — — 37.9% 60.1%
Operating margin — 58.1% 19.7% — 62.6% 3.2% 35.3%
Operating margin, 3-year average — 67.9% 15.9% — 83.2% −10.7% 35.7%
Net margin 62.2% 38.6% 4.0% 7.8% 38.9% −16.7% 7.8%
Cash from operations / revenue 78.2% 57.5% 44.2% 43.6% 40.7% 14.7% 41.7%
Free-cash-flow margin 58.3% 36.5% 9.7% 19.0% 37.5% 6.9% 15.1%
Free-cash-flow margin, 3-year average 59.7% 39.0% 23.6% 20.4% 47.6% −10.1% 19.1%
Stock pay / revenue 2.0% 1.5% 2.1% 1.8% 2.5% 1.6% 1.6%
Change in share count 23.8% 5.7% 6.1% 5.9% 7.4% 29.5% 6.1%

Median of all 17 companies we cover in health care reits. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

17 health care reits companies
Measure Company Peer median Rank
Revenue growth Growth 53.0% 15.0% 2 of 17
Change in growth rate Growth -5.4pp +1.1pp 16 of 17
Net margin Profitability 62.2% 7.8% 2 of 17
Stock pay as % of revenue Cash generation 2.0% 1.8% 10 of 16
Long-term debt as % of assets Balance sheet 20.3% 47.4% 1 of 14
Change in share count Balance sheet 23.8% 6.1% 15 of 17

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$10.1B
Institutions reporting
512
Shares held vs prior quarter
▲ 8.8%
Positions opened / closed
64 / 37

Top buyers and sellers, Q2 2026: 277 institutions bought and 199 sold ; the biggest buyer was Blackrock, Inc (+4.8M shares) and the biggest seller Wellington Management Group LLP (−2.1M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $1.6B 40.7M 16.2% ▲ 13.5%
Vanguard Portfolio Management LLC $843M 20.9M 8.3% ▲ 5.0%
Cohen & Steers, Inc. $515M 12.8M 5.1% ▲ 6.4%
State Street Corp $507M 12.4M 5.0% ▲ 3.4%
Vanguard Capital Management LLC $429M 10.6M 4.2% ▲ 6.4%
FMR LLC $424M 10.5M 4.2% ▲ 4.6%
T. Rowe Price Investment Management, Inc. $409M 10.1M 4.0% ▲ 13.6%
Wellington Management Group LLP $391M 9.7M 3.9% ▼ 18.0%
Geode Capital Management, LLC $302M 7.5M 3.0% ▲ 7.2%
Nuveen, LLC $203M 5.0M 2.0% ▲ 13.3%
Charles Schwab Investment Management Inc $189M 4.7M 1.9% ▲ 9.8%
Deutsche Bank Ag\ $144M 3.6M 1.4% ▲ 4.5%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Caretrust Reit, Inc.'s complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 1 trade and filings

No trades in Caretrust Reit, Inc. disclosed in the last 12 months; 1 earlier trade on record.

  • Daniel S. Goldman(D-NY 10):Sale (full), $1,001 - $15,000, traded July 12, 2023, filed August 13, 2023

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around November 4, 2026 estimated from the company's past filing pattern, not announced

  • August 6, 2026
  • May 7, 2026
  • February 12, 2026
  • November 5, 2025
  • August 6, 2025
  • May 1, 2025

Recent SEC filings

Data status

When each part of this page on Caretrust Reit, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Caretrust Reit, Inc. in brief

What does Caretrust Reit, Inc. do?
Caretrust Reit, Inc. is a US-listed company in the health care REITs industry. Its financial year ends in December.
What is Caretrust Reit, Inc.'s stock ticker?
Caretrust Reit, Inc. trades under the ticker CTRE on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Caretrust Reit, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Caretrust Reit, Inc. reported revenue of $571M, 53.0% higher than a year earlier, according to its SEC filings.
What is Caretrust Reit, Inc.'s free cash flow?
Caretrust Reit, Inc.'s free-cash-flow margin is 58.3% of revenue over the trailing twelve months.
Who are Caretrust Reit, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Portfolio Management LLC and Cohen & Steers, Inc. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Caretrust Reit, Inc.'s market cap?
On November 2, 2026, Caretrust Reit, Inc.'s market capitalisation was about $8.1B, with a price-to-earnings ratio of 22.7 and net debt of $1.2B. Market figures come from third-party market data and may be delayed.
Does Caretrust Reit, Inc. pay a dividend?
Yes: Caretrust Reit, Inc. paid $305M in dividends over the trailing twelve months, a dividend yield of 3.58% and a payout ratio of 85.9%.
Who are Caretrust Reit, Inc.'s competitors?
In our Health Care REITs peer group, the companies closest to Caretrust Reit, Inc. are National Health Investors Inc, Easterly Government Properties, Inc., Sabra Health Care Reit, Inc., LTC Properties Inc and National Healthcare Properties, Inc. The side-by-side comparison below sets their revenue, margins and growth against Caretrust Reit, Inc.'s.
When is Caretrust Reit, Inc.'s next earnings date?
Around November 5, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Caretrust Reit, Inc. announces its own schedule.